Canada Specialty Pharmacy Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2030

back-icon

Back to Report

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Free Sample Report Free Sample Report Inquire Before Buying Inquire Before Buy Now Buy Now

Canada Specialty Pharmacy Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2030

  • Pharmaceutical
  • Published Report
  • Apr 2025
  • Country Level
  • 350 Pages
  • No of Tables: 10
  • No of Figures: 27

Table of Content

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE CANADA SPECIALTY PHARMACY MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 SERVICES LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.1 VENDOR SHARE ANALYSIS

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTAL ANALYSIS

4.2 PORTERS FIVE FORCES ANALYSIS

5 CANADA SPECIALTY PHARMACY MARKET: REGULATIONS

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 INCREASING PREVALENCE OF CHRONIC AND RARE DISEASES

6.1.2 INCREASING GERIATRIC POPULATION

6.1.3 INCREASING NUMBER OF DISTRIBUTION CHANNELS FOR SPECIALITY DRUGS

6.2 RESTRAINTS

6.2.1 STRINGENT REGULATORY FRAMEWORK

6.2.2 LACK OF SKILLED PHARMACISTS

6.3 OPPORTUNITIES

6.3.1 EMERGING MARKETS OF SPECIALTY PHARMACIES

6.3.2 RISING E-PHARMACIES FACILITIES

6.4 CHALLENGES

6.4.1 LACK OF AWARENESS AMONG CONSUMERS ABOUT SPECIALTY PHARMACIES

6.4.2 INSUFFICIENT FUNDING FOR SPECIALITY PHARMACIES

7 CANADA SPECIALTY PHARMACY MARKET, BY TYPE

7.1 OVERVIEW

7.2 LARGE PHARMACY BENEFIT MANAGER (PBM)

7.2.1 MANUFACTURER-OWNED SPECIALTY PHARMACIES

7.2.2 OWNED SPECIALTY PHARMACIES

7.3 SMALL-INDEPENDENT PHARMACY SERVICE PROVIDERS

8 CANADA SPECIALTY PHARMACY MARKET, BY SERVICE TYPE

8.1 OVERVIEW

8.2 CLINICAL SERVICES

8.2.1 COMPOUNDING

8.2.2 AUTO-REFILLS/REFILLS

8.2.3 BLISTER PACKAGING

8.2.4 MEDICAL CONSULTATIONS

8.2.5 CARE MANAGEMENT

8.2.6 PATIENT ADHERENCE PROGRAMS

8.2.7 HEALTH CARE PROVIDER ACCESS

8.2.8 CLINICAL OUTCOME MEASURES

8.2.9 RISK EVALUATION AND MITIGATION STRATEGIES (REMS) PROGRAMS

8.3 OPERATIONAL SERVICES

8.3.1 SUPPLY CHAIN MANAGEMENT

8.3.2 CARE COORDINATION

8.3.3 INSURANCE NAVIGATION

8.3.4 PATIENT ASSISTANCE

8.3.5 PLAN OPTIMIZATION

9 CANADA SPECIALTY PHARMACY MARKET, BY CONDITION

9.1 OVERVIEW

9.2 CANCER

9.3 RHEUMATOID ARTHRITIS

9.4 MULTIPLE SCLEROSIS

9.5 OSTEOARTHRITIS

9.6 INFERTILITY

9.7 HIV

9.8 PULMONARY HYPERTENSION

9.9 IMMUNE DEFICIENCY

9.1 ANEMIA

9.11 HEMOPHILIA

9.12 PSORIASIS

9.13 CYSTIC FIBROSIS

9.14 ULCERATIVE COLITIS

9.15 CROHN'S DISEASE

9.16 JUVENILE IDIOPATHIC ARTHRITIS

9.17 GROWTH HORMONE DEFICIENCIES

9.18 HEPATITIS C VIRUS

9.19 OTHERS

10 CANADA SPECIALTY PHARMACY MARKET, COMPANY LANDSCAPE

10.1 COMPANY SHARE ANALYSIS: GLOBAL

11 SWOT ANALYSIS

12 COMPANY PROFILES

12.1 MCKESSON CANADA

12.1.1 COMPANY SNAPSHOT

12.1.2 SERVICE PORTFOLIO

12.1.3 RECENT DEVELOPMENTS

12.2 SOBEYS INC.

12.2.1 COMPANY SNAPSHOT

12.2.2 SERVICE PORTFOLIO

12.2.3 RECENT DEVELOPMENTS

12.3 REXALL PHARMACY GROUP LTD.

12.3.1 COMPANY SNAPSHOT

12.3.2 SERVICE PORTFOLIO

12.3.3 RECENT DEVELOPMENTS

12.4 BAYSHORE HEALTHCARE

12.4.1 COMPANY SNAPSHOT

12.4.2 SERVICE PORTFOLIO

12.4.3 RECENT DEVELOPMENTS

12.5 PHARMASAVE

12.5.1 COMPANY SNAPSHOT

12.5.2 SERVICE PORTFOLIO

12.5.3 RECENT DEVELOPMENTS

12.6 AARONSON'S COMPOUNDING PHARMACY

12.6.1 COMPANY SNAPSHOT

12.6.2 SERVICE PORTFOLIO

12.6.3 RECENT DEVELOPMENTS

12.7 ANCHOR COMPOUNDING PHARMACY

12.7.1 COMPANY SNAPSHOT

12.7.2 SERVICE PORTFOLIO

12.7.3 RECENT DEVELOPMENTS

12.8 ABBY PHARMACY

12.8.1 COMPANY SNAPSHOT

12.8.2 SERVICE PORTFOLIO

12.8.3 RECENT DEVELOPMENTS

12.9 AURORA HEALTHCARE

12.9.1 COMPANY SNAPSHOT

12.9.2 SERVICE PORTFOLIO

12.9.3 RECENT DEVELOPMENTS

12.1 ALLCURES PHARMACY

12.10.1 COMPANY SNAPSHOT

12.10.2 SERVICE PORTFOLIO

12.10.3 RECENT DEVELOPMENTS

12.11 ALPINE DRUG MART I.D.A.

12.11.1 COMPANY SNAPSHOT

12.11.2 PRODUCT PORTFOLIO

12.11.3 RECENT DEVELOPMENTS

12.12 ANDREEN'S PHARMACY

12.12.1 COMPANY SNAPSHOT

12.12.2 SERVICE PORTFOLIO

12.12.3 RECENT DEVELOPMENTS

12.13 BRUNSKILLPHARMACY

12.13.1 COMPANY SNAPSHOT

12.13.2 SERVICE PORTFOLIO

12.13.3 RECENT DEVELOPMENTS

12.14 BAINS PHARMACY

12.14.1 COMPANY SNAPSHOT

12.14.2 PRODUCT PORTFOLIO

12.14.3 RECENT DEVELOPMENTS

12.15 BIOSCRIPT SOLUTIONS

12.15.1 COMPANY SNAPSHOT

12.15.2 SERVICE PORTFOLIO

12.15.3 RECENT DEVELOPMENTS

12.16 BUDGET PHARMACY

12.16.1 COMPANY SNAPSHOT

12.16.2 SERVICE PORTFOLIO

12.16.3 RECENT DEVELOPMENTS

12.17 BALANCED HEALTH INTEGRATIVE PHARMACY

12.17.1 COMPANY SNAPSHOT

12.17.2 SERVICE PORTFOLIO

12.17.3 RECENT DEVELOPMENTS

12.18 COMPOUNDING PHARMACY NEW WESTMINSTER - LONGEVITY PHARMACY

12.18.1 COMPANY SNAPSHOT

12.18.2 SERVICE PORTFOLIO

12.18.3 RECENT DEVELOPMENTS

12.19 CITY LIFE PHARMACY

12.19.1 COMPANY SNAPSHOT

12.19.2 SERVICE PORTFOLIO

12.19.3 RECENT DEVELOPMENTS

12.2 CREATE COMPOUNDING LIMITED

12.20.1 COMPANY SNAPSHOT

12.20.2 SERVICE PORTFOLIO

12.20.3 RECENT DEVELOPMENTS

12.21 CONCORD SPECIALTY PHARMACY

12.21.1 COMPANY SNAPSHOT

12.21.2 SERVICE PORTFOLIO

12.21.3 RECENT DEVELOPMENTS

12.22 360CARE DENMAN PHARMACY

12.22.1 COMPANY SNAPSHOT

12.22.2 SERVICE PORTFOLIO

12.22.3 RECENT DEVELOPMENTS

12.23 DYNASTY PHARMACY

12.23.1 COMPANY SNAPSHOT

12.23.2 SERVICE PORTFOLIO

12.23.3 RECENT DEVELOPMENTS

12.24 EXTEND PHARMACY

12.24.1 COMPANY SNAPSHOT

12.24.2 SERVICE PORTFOLIO

12.24.3 RECENT DEVELOPMENTS

12.25 LONDON DRUGS

12.25.1 COMPANY SNAPSHOT

12.25.2 SERVICE PORTFOLIO

12.25.3 RECENT DEVELOPMENTS

12.26 LOVELL DRUGS

12.26.1 COMPANY SNAPSHOT

12.26.2 SERVICE PORTFOLIO

12.26.3 RECENT DEVELOPMENTS

12.27 MEDICINE CENTRE

12.27.1 COMPANY SNAPSHOT

12.27.2 SERVICE PORTFOLIO

12.27.3 RECENT DEVELOPMENTS

12.28 MOUNTAIN HEALTH CO-OP

12.28.1 COMPANY SNAPSHOT

12.28.2 SERVICE PORTFOLIO

12.28.3 RECENT DEVELOPMENTS

12.29 MEDS WEST LTD.

12.29.1 COMPANY SNAPSHOT

12.29.2 SERVICE PORTFOLIO

12.29.3 RECENT DEVELOPMENTS

12.3 MCCALLUM PHARMACY

12.30.1 COMPANY SNAPSHOT

12.30.2 SERVICE PORTFOLIO

12.30.3 RECENT DEVELOPMENTS

12.31 NORTHMOUNT PHARMACY AND COMPOUNDING LAB

12.31.1 COMPANY SNAPSHOT

12.31.2 SERVICE PORTFOLIO

12.31.3 RECENT DEVELOPMENTS

12.32 NKS HEALTH

12.32.1 COMPANY SNAPSHOT

12.32.2 SERVICE PORTFOLIO

12.32.3 RECENT DEVELOPMENTS

12.33 ONPHARM-UNITED

12.33.1 COMPANY SNAPSHOT

12.33.2 SERVICE PORTFOLIO

12.33.3 RECENT DEVELOPMENTS

12.34 OMNICARE PHARMACY

12.34.1 COMPANY SNAPSHOT

12.34.2 SERVICE PORTFOLIO

12.34.3 RECENT DEVELOPMENTS

12.35 OMNICELL INC.

12.35.1 COMPANY SNAPSHOT

12.35.2 REVENUE ANALYSIS

12.35.3 SERVICE PORTFOLIO

12.35.4 RECENT DEVELOPMENT

12.36 PHARMACHOICE CANADA INC.

12.36.1 COMPANY SNAPSHOT

12.36.2 SERVICE PORTFOLIO

12.36.3 RECENT DEVELOPMENTS

12.37 PRATT'S COMPOUNDING PHARMACY

12.37.1 COMPANY SNAPSHOT

12.37.2 SERVICE PORTFOLIO

12.37.3 RECENT DEVELOPMENTS

12.38 PACE PHARMACY

12.38.1 COMPANY SNAPSHOT

12.38.2 SERVICE PORTFOLIO

12.38.3 RECENT DEVELOPMENTS

12.39 QUIICK MEDICINE

12.39.1 COMPANY SNAPSHOT

12.39.2 SERVICE PORTFOLIO

12.39.3 RECENT DEVELOPMENTS

12.4 RX CONNECT

12.40.1 COMPANY SNAPSHOT

12.40.2 SERVICE PORTFOLIO

12.40.3 RECENT DEVELOPMENTS

12.41 RIVERVIEWGUARDIAN.CA

12.41.1 COMPANY SNAPSHOT

12.41.2 SERVICE PORTFOLIO

12.41.3 RECENT DEVELOPMENTS

12.42 RESIDENT CARE PHARMACY

12.42.1 COMPANY SNAPSHOT

12.42.2 SERVICE PORTFOLIO

12.42.3 RECENT DEVELOPMENTS

12.43 SHERMANSPECIALTY PHARMACY

12.43.1 COMPANY SNAPSHOT

12.43.2 SERVICE PORTFOLIO

12.43.3 3.43.3. RECENT DEVELOPMENTS

12.44 SHOPPERS DRUG MART SPECIALTY HEALTH NETWORK INC.

12.44.1 COMPANY SNAPSHOT

12.44.2 SERVICE PORTFOLIO

12.44.3 RECENT DEVELOPMENTS

12.45 SRX HEALTH

12.45.1 COMPANY SNAPSHOT

12.45.2 SERVICE PORTFOLIO

12.45.3 RECENT DEVELOPMENTS

12.46 SENTREX HEALTH SOLUTIONS

12.46.1 COMPANY SNAPSHOT

12.46.2 SERVICE PORTFOLIO

12.46.3 RECENT DEVELOPMENTS

12.47 TORANI AND HADDAD PHARMACY SPEC- PHARMA

12.47.1 COMPANY SNAPSHOT

12.47.2 SERVICE PORTFOLIO

12.47.3 RECENT DEVELOPMENTS

12.48 TOTAL PHARMACY

12.48.1 COMPANY SNAPSHOT

12.48.2 SERVICE PORTFOLIO

12.48.3 RECENT DEVELOPMENTS

12.49 VICTORIA COMPOUNDING PHARMACY

12.49.1 COMPANY SNAPSHOT

12.49.2 SERVICE PORTFOLIO

12.49.3 RECENT DEVELOPMENTS

12.5 WEST END PHARMACY

12.50.1 COMPANY SNAPSHOT

12.50.2 SERVICE PORTFOLIO

12.50.3 RECENT DEVELOPMENTS

13 QUESTIONNAIRE

14 RELATED REPORTS

List of Table

TABLE 1 CANADA SPECIALTY PHARMACY MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 2 CANADA LARGE PHARMACY BENEFIT MANAGER (PBM) IN SPECIALTY PHARMACY MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 3 CANADA SPECIALTY PHARMACY MARKET, BY SERVICE TYPE, 2018-2032 (USD MILLION)

TABLE 4 CANADA CLINICAL SERVICES IN SPECIALTY PHARMACY MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 5 CANADA MEDICAL CONSULTATIONS IN SPECIALTY PHARMACY MARKET, BY TYPE 2018-2032 (USD MILLION)

TABLE 6 CANADA RISK EVALUATION AND MITIGATION STRATEGY (REMS) PROGRAMS IN SPECIALTY PHARMACY MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 7 CANADA OPERATIONAL SERVICES IN SPECIALTY PHARMACY MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 8 CANADA SUPPLY CHAIN MANAGEMENT IN SPECIALTY PHARMACY MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 9 CANADA INSURANCE NAVIGATION IN SPECIALTY PHARMACY MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 10 CANADA SPECIALTY PHARMACY MARKET, BY CONDITION, 2018-2032 (USD MILLION)

List of Figure

FIGURE 1 CANADA SPECIALTY PHARMACY MARKET: SEGMENTATION

FIGURE 2 CANADA SPECIALTY PHARMACY MARKET: DATA TRIANGULATION

FIGURE 3 CANADA SPECIALTY PHARMACY MARKET: DROC ANALYSIS

FIGURE 4 CANADA SPECIALTY PHARMACY MARKET: COUNTRYWISE MARKET ANALYSIS

FIGURE 5 CANADA SPECIALTY PHARMACY MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 CANADA SPECIALTY PHARMACY MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 CANADA SPECIALTY PHARMACY MARKET: DBMR MARKET POSITION GRID

FIGURE 8 CANADA SPECIALTY PHARMACY MARKET: DBMR VENDOR SHARE ANALYSIS

FIGURE 9 CANADA SPECIALTY PHARMACY MARKET: SEGMENTATION

FIGURE 10 THREE SEGMENTS COMPRISE THE CANADA SPECIALTY PHARMACY MARKET, BY SERVICE TYPE (2024)

FIGURE 11 STRATEGIC DECISIONS

FIGURE 12 AN INCREASE IN THE PREVALENCE OF CHRONIC AND RARE DISEASES IS EXPECTED TO BOOST THE CANADA SPECIALTY PHARMACY MARKET IN THE FORECAST PERIOD OF 2025 TO 2032

FIGURE 13 THE CLINICAL SERVICES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE CANADA SPECIALTY PHARMACY MARKET IN 2025 & 2032

FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF CANADA SPECIALITY PHARMACY MARKET

FIGURE 15 CANADA SPECIALTY PHARMACY MARKET: BY TYPE, 2024

FIGURE 16 CANADA SPECIALTY PHARMACY MARKET: BY TYPE, 2025-2032 (USD MILLION)

FIGURE 17 CANADA SPECIALTY PHARMACY MARKET: BY TYPE, CAGR (2025-2032)

FIGURE 18 CANADA SPECIALTY PHARMACY MARKET: BY TYPE, LIFELINE CURVE

FIGURE 19 CANADA SPECIALTY PHARMACY MARKET: BY SERVICE TYPE, 2024

FIGURE 20 CANADA SPECIALTY PHARMACY MARKET: BY SERVICE TYPE, 2025-2032 (USD MILLION)

FIGURE 21 CANADA SPECIALTY PHARMACY MARKET: BY SERVICE TYPE, CAGR (2025-2032)

FIGURE 22 CANADA SPECIALTY PHARMACY MARKET: BY SERVICE TYPE, LIFELINE CURVE

FIGURE 23 CANADA SPECIALTY PHARMACY MARKET: BY CONDITION, 2024

FIGURE 24 CANADA SPECIALTY PHARMACY MARKET: BY CONDITION, 2025-2032 (USD MILLION)

FIGURE 25 CANADA SPECIALTY PHARMACY MARKET: BY CONDITION, CAGR (2025-2032)

FIGURE 26 CANADA SPECIALTY PHARMACY MARKET: BY CONDITION, LIFELINE CURVE

FIGURE 27 CANADA SPECIALTY PHARMACY MARKET: COMPANY SHARE 2024 (%)